Buscar resultados de ensayos clínicos
Crohn Disease - 43 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease Condición: Crohn's Disease Fecha: 2014-01-09 Intervenciones:
|
Completed |
Nombre del estudio: Study for the Treatment of Crohn's Disease With Adacolumn Condición: Crohn's Disease Fecha: 2005-09-09 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Extension Study of MT-1303 in Subjects With Crohn's Disease Condición: Crohn's Disease Fecha: 2015-03-10 Intervenciones: Drug: MT-1303 |
Completed |
Nombre del estudio: Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity Condición: Crohn's Disease Fecha: 2007-07-02 Intervenciones:
|
Recruiting |
Nombre del estudio: Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease Condición: Crohn's Disease Fecha: 2014-07-16 Intervenciones:
|
Completed |
Nombre del estudio: Safety and Maintenance Study of Entocort for Children With Crohn's Disease Condición: Crohn's Disease Fecha: 2011-10-14 Intervenciones: Drug: Entocort Entocort capsules, taken orally, 6 mg daily. |
Completed |
Nombre del estudio: An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease Condición: Crohn Disease Fecha: 2005-12-22 Intervenciones:
|
Terminated |
Nombre del estudio: Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease Condición: Crohn's Disease Fecha: 2005-08-12 Intervenciones:
|
Completed |
Nombre del estudio: Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease Condición: Crohn's Disease Fecha: 2014-05-20 Intervenciones: Drug: MT-1303 |
Completed |
Nombre del estudio: A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease Condición: Crohn Disease Fecha: 2005-09-13 Intervenciones: Drug: infliximab or placebo |